Gastrointestinal stromal tumors: New progress, new questions

Current Opinion in Gastroenterology

Volumn 20, Issue 5, 2004, Pages 482-487

  Nickl, Nicholas J ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Endoscopic ultrasound; Endosonography; Gastrointestinal stromal tumor; Imatinib; KIT; Mesenchymal tumors

Indexed keywords

IMATINIB; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; STAT PROTEIN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

BLEEDING; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; GENE MUTATION; HEALTH CARE ORGANIZATION; HUMAN; INTERSTITIAL CELL OF CAJAL; LAPAROSCOPIC SURGERY; LEIOMYOMA; NEEDLE BIOPSY; ONCOGENE; PATHOGENESIS; PATHOLOGY; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR NECROSIS; ULTRASOUND;

EID: 4344564668     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200409000-00011     Document Type: Review

References (33)

1. Miettinen M, Sarlomo-Rikala M, Lasota J: Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999, 30:1213-1220.
2. Hedenbro JL, Ekelund M, Wetterberg P: Endoscopic diagnosis of submucosal gastric lesions: the results after routine endoscopy. Surg Endosc 1991, 5:20-30.
3. Rösch T, Kapfer B, Will U, et al.: Accuracy of endoscopic ultrasonography in upper gastrointestinal submucosal lesions: a prospective multicenter study. Scand J Gastroenterol 2002, 37:856-862. This paper examines several endosonographic features for correlation with histology.
4. Rohatgi A, Singh KK: Laparoendoscopic management of gastrointestinal stromal tumors. J Laparoendosc Adv Surg Tech 2003, 13:37-40.
5. Rosch T: Endoscopic ultrasonography in upper gastrointestinal submucosal tumors: a literature review. Gastrointest Endosc Clin North Am 1995, 5:609-614.
6. Yasuda K, Cho E, Nakajima M, Kawai K: Diagnosis of submucosal lesions of the upper gastrointestinal tract by endoscopic ultrasonography. Gastrointest Endosc 1990, 36:S17-20.
7. Nickl N, Gress F, McClave S, et al.: Hypoechoic intramural tumor study: final report. Gastrointest Endosc 2002, 55:AB98.
8. Rosch T, Lorenz R, Dancygier H, et al.: Endosonographic diagnosis of submucosal upper gastrointestinal tract tumors. Scand J Gastroenterol 1992, 27:1-8.
9. Chak A, Canto MI, Rosch T, et al.: Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc 1997, 45:468-473.
10. Palazzo L, Landi B, Cellier C, et al.: Endosonographic features predictive of benign and malignant gastrointestinal stromal tumors. Gut 2000, 48:88-92.
11. Tsai TL, Changcdhien CS, Hu TH, et al.: Differentiation of benign and malignant gastric stromal tumors using endoscopic ultrasonography. Chang Gung Med J 2001, 24:167-173.
12. Matsui M, Goto H, Niwa Y, et al.: Preliminary results of fine needle aspiration biopsy histology in upper gastrointestinal submucosal tumors. Endoscopy 1998, 30:750-755.
13. Gu M, Ghafari S, Nguyen PT, Lin F: Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasound guided fine needle aspiration biopsy: cytomorphologic and immunohistochemical study of 12 cases. Diagn Cytopathol 2001, 25:343-350.
14. Ando N, Goto H, Niwa Y, et al.: The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration and immunohistochemical analysis. Gastrointest Endosc 2002, 55:37-43.
15. Davila RE, Faigel DO: GI stromal tumors. Gastrointest Endosc 2003, 58:80-88. This is an excellent review of GIST containing additional background details.
16. Lewin K, Riddel RH, Weinstein WM: Mesenchymal tumors. In: Gastrointestinal Pathology and Its Clinical Implications. New York: Igaku-Shoin, 1992:284-341.
17. Berman JJ, O'Leary TJ: Gastrointestinal stromal tumor workshop. Hum Pathol 2001, 32:578-582.
18. Fletcher CD, Berman JJ, Corless C, et al.: Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002, 33:459-465. This is the NIH consensus report regarding pathological criteria for GIST.
19. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinem M: CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11:728-734.
20. Duffaud F, Blay JY: Gastrointestinal stromal tumors: biology and treatment. Oncology 2003, 65:187-197. This is an excellent review of the biochemistry of GIST.
21. Heinrich MC, Corless CL, Duensing A, et al.: PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003, 299:708-710.
22. Hirohita S, Osizaki K, Moriyama Y: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998, 279:577-580.
23. Kimata M, Kubota T, Otani Y: Gastrointestinal stromal tumors treated by laparoscopic surgery: report of three cases. Surg Today 2000, 30:177-180.
24. Pross M, Wolff S, Schubert D, et al.: Combined minimal-invasive procedures for resection of benign gastric wall tumors. Zentralbl Chir 2003, 128:191-194.
25. Walsh RM, Ponsky J, Brody F, et al.: Combined endoscopic/laparoscopic intragastric resection of gastric stromal tumors. J Gastrointest Surg 2003, 7:386-392.
26. Andrales G, Pollinger H, Kercher K, et al.: The applicability and outcome of laparoscopic gastric resection. Gastroenterol 2002, 123(suppl):90.
27. Park A, Nickl N. Unpublished data.
28. Nickl N, Wackerbarth S, Gress F, et al.: Management of hypoechoic intramural tumors: a decision tree analysis of EUS directed vs. surgical management. Gastrointest Endosc 2000, 51(4 part 2):AB176.
29. Heinrich MC, Griffith DJ, Druker BJ, et al.: Inhibition of c-kit receptor tyrosine kinase activity by STI571, a selective tyrosine kinase inhibitor. Blood 2000, 96:925-932.
30. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al.: Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001, 344:1052-1056.
31. Van Oosterom AT, Judson I, Verweij J, et al.: Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase 1 study. Lancet 2001, 358:1421-1523.
32. Demetri GD, von Mehren M, Blanke CD, et al.: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347:472-480. This is the largest prospective study of the effectiveness of imatinib in the treatment of malignant GIST.
33. Heinrich MC, Corless CL, Demetri GD, et al.: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003, 21:4342-4349.